{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T14:58:54Z","timestamp":1788188334298,"version":"build-2803163510"},"reference-count":42,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2014,1,31]],"date-time":"2014-01-31T00:00:00Z","timestamp":1391126400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0085886","type":"journal-article","created":{"date-parts":[[2014,1,31]],"date-time":"2014-01-31T22:33:48Z","timestamp":1391207628000},"page":"e85886","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":26,"title":["Subclinical Elevation of Plasma C-Reactive Protein and Illusions\/Hallucinations in Subjects with Parkinson\u2019s Disease: Case\u2013control Study"],"prefix":"10.1371","volume":"9","author":[{"given":"Hideyuki","family":"Sawada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoko","family":"Oeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Umemura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Tomita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryutaro","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Kohsaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Sudoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Sugiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,1,31]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/S1474-4422(10)70212-X","article-title":"Neuropsychological and clinical heterogeneity of cognitive impairment and dementia in patients with Parkinson\u2019s disease","volume":"9","author":"AA Kehagia","year":"2010","journal-title":"Lancet Neurol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jns.2006.05.021","article-title":"Non-dopaminergic treatment of cognitive impairment and dementia in Parkinson\u2019s disease: a review","volume":"248","author":"I Leroi","year":"2006","journal-title":"J Neurol Sci"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.parkreldis.2005.06.011","article-title":"Caregiver-burden in parkinson\u2019s disease is closely associated with psychiatric symptoms, falls, and disability","volume":"12","author":"A Schrag","year":"2006","journal-title":"Parkinsonism Relat Disord"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1212\/WNL.43.11.2227","article-title":"Risk factors for nursing home placement in advanced Parkinson\u2019s disease","volume":"43","author":"CG Goetz","year":"1993","journal-title":"Neurology"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1212\/01.WNL.0000068010.82167.CF","article-title":"Longitudinal outcome of Parkinson\u2019s disease patients with psychosis","volume":"60","author":"SA Factor","year":"2003","journal-title":"Neurology"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1212\/WNL.0b013e3181f61311","article-title":"What predicts mortality in Parkinson disease?: a prospective population-based long-term study","volume":"75","author":"EB Forsaa","year":"2010","journal-title":"Neurology"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1002\/mds.21382","article-title":"Diagnostic criteria for psychosis in Parkinson\u2019s disease: report of an NINDS, NIMH work group","volume":"22","author":"B Ravina","year":"2007","journal-title":"Mov Disord"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/mds.20263","article-title":"Hallucinations in Parkinson\u2019s disease: a follow-up study","volume":"20","author":"AD de Maindreville","year":"2005","journal-title":"Mov Disord"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.parkreldis.2010.05.004","article-title":"Parkinson\u2019s disease psychosis 2010: a review article","volume":"16","author":"JH Friedman","year":"2010","journal-title":"Parkinsonism Relat Disord"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1093\/brain\/123.4.733","article-title":"Hallucinations in Parkinson\u2019s disease: prevalence, phenomenology and risk factors","volume":"4)","author":"G Fenelon","year":"2000","journal-title":"Brain 123 (Pt"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1002\/mds.22839","article-title":"The changing face of Parkinson\u2019s disease-associated psychosis: a cross-sectional study based on the new NINDS-NIMH criteria","volume":"25","author":"G Fenelon","year":"2010","journal-title":"Mov Disord"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1001\/archneurol.2010.166","article-title":"A 12-year population-based study of psychosis in Parkinson disease","volume":"67","author":"EB Forsaa","year":"2010","journal-title":"Arch Neurol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1136\/jnnp.63.4.434","article-title":"Hallucinosis in idiopathic Parkinson\u2019s disease","volume":"63","author":"JM Graham","year":"1997","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1002\/mds.25003","article-title":"Psychosis in Parkinson\u2019s disease without dementia: Common and comorbid with other non-motor symptoms","volume":"27","author":"AH Lee","year":"2012","journal-title":"Mov Disord"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S1474-4422(05)70146-0","article-title":"Visual hallucinations in the diagnosis of idiopathic Parkinson\u2019s disease: a retrospective autopsy study","volume":"4","author":"DR Williams","year":"2005","journal-title":"Lancet Neurol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/1471-2377-13-145","article-title":"Trigger medications and patient-related risk factors for Parkinson disease psychosis requiring anti-psychotic drugs: a retrospective cohort study","volume":"13","author":"H Sawada","year":"2013","journal-title":"BMC Neurol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1002\/mds.20582","article-title":"Relationship between hallucinations, delusions, and rapid eye movement sleep behavior disorder in Parkinson\u2019s disease","volume":"20","author":"C Pacchetti","year":"2005","journal-title":"Mov Disord"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1212\/WNL.57.11.2078","article-title":"Prospective longitudinal assessment of hallucinations in Parkinson\u2019s disease","volume":"57","author":"CG Goetz","year":"2001","journal-title":"Neurology"},{"key":"ref19","first-page":"130","article-title":"Psychiatric symptoms following surgery for Parkinson\u2019s disease with an emphasis on subthalamic stimulation","volume":"96","author":"V Voon","year":"2005","journal-title":"Adv Neurol"},{"key":"ref20","first-page":"1060","article-title":"Development and evaluation of the Parkinson Psychosis Questionnaire A screening-instrument for the early diagnosis of drug-induced psychosis in Parkinson\u2019s disease","volume":"252","author":"D Brandstaedter","year":"2005","journal-title":"J Neurol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1136\/jnnp.2008.152579","article-title":"When a Parkinson\u2019s disease patient starts to hallucinate","volume":"8","author":"W Poewe","year":"2008","journal-title":"Pract Neurol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1161\/01.CIR.0000080289.72166.CF","article-title":"Plasma concentration of C-reactive protein and the calculated Framingham Coronary Heart Disease Risk Score","volume":"108","author":"MA Albert","year":"2003","journal-title":"Circulation"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/S0140-6736(09)61717-7","article-title":"C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis","volume":"375","author":"C Emerging Risk Factors","year":"2010","journal-title":"Lancet"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1159\/000222780","article-title":"Is there an association between the level of high-sensitivity C-reactive protein and idiopathic Parkinson\u2019s disease? A comparison of Parkinson\u2019s disease patients, disease controls and healthy individuals","volume":"62","author":"IU Song","year":"2009","journal-title":"Eur Neurol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s10072-010-0335-0","article-title":"Association between high-sensitivity C-reactive protein and risk of early idiopathic Parkinson\u2019s disease","volume":"32","author":"IU Song","year":"2011","journal-title":"Neurol Sci"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1007\/s00702-010-0428-1","article-title":"Neuroinflammation is a key player in Parkinson\u2019s disease and a prime target for therapy","volume":"117","author":"L Qian","year":"2010","journal-title":"J Neural Transm"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"e003533","DOI":"10.1136\/bmjopen-2013-003533","article-title":"Protocol for a randomised controlled trial: efficacy of donepezil against psychosis in Parkinson\u2019s disease (EDAP)","volume":"3","author":"H Sawada","year":"2013","journal-title":"BMJ Open"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease","volume":"7","author":"GM McKhann","year":"2011","journal-title":"Alzheimers Dement"},{"key":"ref29","first-page":"518","article-title":"Hallucinations and delusions in patients with Parkinson\u2019s disease\u2013Evaluation by the Parkinson Pschosis Questionnaire","volume":"18","author":"H Sawada","year":"2011","journal-title":"Eur J Neurol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s13760-012-0027-z","article-title":"Hallucinations in Parkinson\u2019s disease: cross-sectional study","volume":"112","author":"M Svetel","year":"2012","journal-title":"Acta Neurol Belg"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jns.2009.04.018","article-title":"Plasma C-reactive protein is related to cognitive deterioration and dementia in patients with mild cognitive impairment","volume":"284","author":"G Xu","year":"2009","journal-title":"J Neurol Sci"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"e47387","DOI":"10.1371\/journal.pone.0047387","article-title":"Non-motor symptoms in patients with Parkinson\u2019s disease - correlations with inflammatory cytokines in serum","volume":"7","author":"D Lindqvist","year":"2012","journal-title":"PLoS One"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1159\/000323779","article-title":"Serum levels of chemokines in Parkinson\u2019s disease","volume":"18","author":"P Scalzo","year":"2011","journal-title":"Neuroimmunomodulation"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.neulet.2009.10.062","article-title":"Serum levels of interleukin-6 are elevated in patients with Parkinson\u2019s disease and correlate with physical performance","volume":"468","author":"P Scalzo","year":"2010","journal-title":"Neurosci Lett"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1186\/1742-2094-9-259","article-title":"The gamma chain subunit of Fc receptors is required for alpha-synuclein-induced pro-inflammatory signaling in microglia","volume":"9","author":"S Cao","year":"2012","journal-title":"J Neuroinflammation"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.nbd.2005.08.002","article-title":"In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson\u2019s disease","volume":"21","author":"A Gerhard","year":"2006","journal-title":"Neurobiol Dis"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"S200","DOI":"10.1016\/S1353-8020(09)70814-4","article-title":"Neuroinflammation in the living brain of Parkinson\u2019s disease","volume":"15","author":"Y Ouchi","year":"2009","journal-title":"Parkinsonism Relat Disord"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s00702-010-0535-z","article-title":"Is C-reactive protein level a marker of advanced motor and neuropsychiatric complications in Parkinson\u2019s disease?","volume":"118","author":"S Hassin-Baer","year":"2011","journal-title":"J Neural Transm"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1212\/WNL.0b013e318225ae07","article-title":"Proinflammatory cytokines, sickness behavior, and Alzheimer disease","volume":"77","author":"C Holmes","year":"2011","journal-title":"Neurology"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.psychres.2011.07.006","article-title":"Inflammation in psychotic disorders: a population-based study","volume":"189","author":"J Suvisaari","year":"2011","journal-title":"Psychiatry Res"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.cyto.2010.02.011","article-title":"CRP-induced levels of oxidative stress are higher in brain than aortic endothelial cells","volume":"50","author":"D Closhen","year":"2010","journal-title":"Cytokine"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"3556","DOI":"10.1002\/jnr.21810","article-title":"Alterations of Fc gamma receptor I and Toll-like receptor 4 mediate the antiinflammatory actions of microglia and astrocytes after adrenaline-induced blood-brain barrier opening in rats","volume":"86","author":"YN Li","year":"2008","journal-title":"J Neurosci Res"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0085886","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,24]],"date-time":"2022-03-24T21:40:39Z","timestamp":1648158039000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0085886"}},"subtitle":[],"editor":[{"given":"Kenji","family":"Hashimoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,1,31]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2014,1,31]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0085886","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1,31]]}}}